The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
AbstractThe Cytotoxic Necrotizing Factor 1 (CNF1), a protein toxin from pathogenic E. coli, modulates the Rho GTPases, thus, directing the organization of the actin cytoskeleton. In the nervous system, the Rho GTPases play a key role in several processes, controlling the morphogenesis of dendritic spines and synaptic plasticity in brain tissues. This review is focused on the peculiar property of CNF1 to enhance brain plasticity in in vivo animal models of central nervous system (CNS) diseases, and on its possible application in therapy. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Travaglione, S.; Loizzo, S.; Ballan, G.; Fiorentini, C.; Fabbri, A. The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases. Toxins 2014, 6, 270-282.
Travaglione S, Loizzo S, Ballan G, Fiorentini C, Fabbri A. The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases. Toxins. 2014; 6(1):270-282.Chicago/Turabian Style
Travaglione, Sara; Loizzo, Stefano; Ballan, Giulia; Fiorentini, Carla; Fabbri, Alessia. 2014. "The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases." Toxins 6, no. 1: 270-282.